{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:01:23Z","timestamp":1762761683396},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.11124\/jbisrir-d-19-00178","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:24:06Z","timestamp":1590711846000},"page":"1781-1787","source":"Crossref","is-referenced-by-count":4,"title":["Outcome measures for disease-modifying therapies in relapsing multiple sclerosis randomized clinical trials: a scoping review protocol"],"prefix":"10.11124","volume":"18","author":[{"given":"Rosa C.","family":"Lucchetta","sequence":"first","affiliation":[]},{"given":"Magda L.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Aline F.","family":"Bonetti","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]},{"given":"Astrid","family":"Wiens","sequence":"additional","affiliation":[]}],"member":"276","published-online":{"date-parts":[[2020,8]]},"reference":[{"issue":"(2)","key":"R2-20221011","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler J"},{"key":"R3-20221011","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"R4-20221011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-9-1","article-title":"The Multiple Sclerosis Risk Sharing Scheme Monitoring Study \u2013 early results and lessons for the future","volume":"9","author":"Pickin","year":"2009","journal-title":"BMC Neurol"},{"issue":"(955)","key":"R6-20221011","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/pgmj.2004.029413","article-title":"Multiple sclerosis: diagnosis and the management of acute relapses","volume":"81","author":"Leary","year":"2005","journal-title":"Postgrad Med J"},{"key":"R7-20221011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/262350","article-title":"Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials","volume":"2014","author":"Lavery","year":"2014","journal-title":"Mult Scler Int"},{"issue":"(9)","key":"R8-20221011","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40263-018-0541-5","article-title":"Disease-modifying therapies for relapsing-remitting multiple sclerosis: a network meta-analysis","volume":"32","author":"Lucchetta","year":"2018","journal-title":"CNS Drugs"},{"issue":"(3)","key":"R9-20221011","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jrsm.46","article-title":"Pooling health-related quality of life outcomes in meta \u2013 analysis \u2013 a tutorial and review of methods for enhancing interpretability","volume":"2","author":"Thorlund","year":"2011","journal-title":"Res Synth Methods"},{"issue":"((Suppl 3))","key":"R10-20221011","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"issue":"(9)","key":"R11-20221011","first-page":"CD011381","article-title":"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis","author":"Tramacere","year":"2015","journal-title":"Cochrane database Syst Rev"},{"key":"R12-20221011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.msard.2016.06.001","article-title":"Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: systematic review and network meta-analysis","volume":"9","author":"Fogarty","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"(8)","key":"R13-20221011","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/03007995.2017.1407303","article-title":"Systematic literature review and network meta-analysis of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis","volume":"34","author":"Siddiqui","year":"2018","journal-title":"Curr Med Res Opin"},{"issue":"(2)","key":"R14-20221011","doi-asserted-by":"crossref","first-page":"88","DOI":"10.14740\/jocmr3168w","article-title":"A multiple treatment comparison of eleven disease-modifying drugs used for multiple sclerosis","volume":"10","author":"Hamidi","year":"2018","journal-title":"J Clin Med Res"},{"key":"R15-20221011","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.msard.2018.08.026","article-title":"Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: a network meta-analysis","volume":"25","author":"Xu","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"(3)","key":"R16-20221011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"(7)","key":"R18-20221011","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.11124\/JBISRIR-D-19-00178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T13:04:52Z","timestamp":1665493492000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.11124\/JBISRIR-D-19-00178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.11124\/jbisrir-d-19-00178","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}